Hydroxychloroquine and Unexplained Recurrent Miscarriage

NACompletedINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

March 10, 2023

Study Completion Date

July 8, 2023

Conditions

Unexplained Recurrent Miscarriage

Interventions

DRUG

Hydroxychloroquine

400mg

DRUG

Folic Acid

5 mg

DRUG

Low-dose aspirin

75 mg

Trial Locations (1)

Abdel-rahman Mahmoud Mohammed, Asyut

All Listed Sponsors

lead

Assiut University

OTHER

NCT04228263 - Hydroxychloroquine and Unexplained Recurrent Miscarriage | Biotech Hunter | Biotech Hunter